Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...

The 12 Best Income Investments for 2023, According to Barron’s

While it might not be a feast now for income-oriented investors, it’s a lot better than the famine that prevailed for much of the past decade. Yields on a range of bond and bond-related investments ro...

The Best Income Investing Ideas for 2023

While it might not be a feast now for income-oriented investors, it’s a lot better than the famine that prevailed for much of the past decade. Yields on a range of bond and bond-related investments ro...

Why Atlanta Tops the Hottest 2023 Real Estate Markets

Atlanta is hot. Georgia’s capital tops the National Association of Realtors’ list of markets to watch in 2023, based on 10 metrics, including housing affordability, employment conditions, and populati...

Cramer shares his outlook on Amgen after the Horizon Therapeutics deal

Horizon Therapeutics Plc (NASDAQ: HZNP) is up nearly 15% on Monday after Amgen Inc (NASDAQ: AMGN) revealed plans of buying the biopharmaceutical company for $27.8 billion. What it means for Horizon sh...

Amgen confirms to acquire Horizon Therapeutics in cash deal valued at about $27.8 billion

Amgen Inc. AMGN, -2.42% said Monday it has agreed to acquire Horizon Therapeutics Plc HZNP, +0.39% in an all-cash deal valued at $27.8 billion, confirming earlier reports and a deal that was first moo...

Horizon Therapeutics, Coupa Software, Rivian, and More Stock Market Movers

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...

MRTX Stock Crashes As Amgen Rivalry Heats Up With New Lung Cancer Data

Mirati Therapeutics (MRTX) said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed Tuesday as investors questioned whether it could take on traditional chemotherapy. ...

4 Advisors on Their Top Bond Buys Now

With bonds offering their juiciest yields in years, we queried some wealth management pros on where they see the best fixed-income opportunities now: David Rossmiller, Bessemer Trust: We like longer b...

It’s Rough Out There. Stick With Dividend Stocks to Stay Afloat.

Dividend stocks are poised to notch an impressive victory this year. The Dow Jones U.S. Select Dividend index is ahead 5.5%, cruising past the S&P 500 index, down 14.4% in total returns. Even more...

Stock Market Looks Poised to Rally as Bond Yield Falls

Text size Michael Nagle/Bloomberg The worst may be over for the stock market. Key equity indexes continued their autumn rally, and there could be more gains before the end of the year, helped by conti...

Will Amgen Stock Skyrocket Through FDA Trials?

| Getty Images Key Takeaways Amgen announced positive results from a phase I trial of its new obesity drug, AMG 133. After its earnings announcement and the trial results, Amgen stock rose more than 5...

Big Pharma Stocks Are Breaking Out. Here Are Some Winners.

Big pharma stocks are trying to break out to new heights. They have reported more-than-satisfactory earnings and are expecting further progress on new pipelines of drugs.   These stocks had been outpe...

Can Amgen Finally Make an Upside Breakout?

Pharmaceutical giant Amgen Inc. (AMGN) has been trading sideways in the $250-$260 area many times since April. The $64,000 question is whether AMGN can stage an upside breakout. Let’s check the ...

Amgen, Uber, Lyft, Zscaler and more

A sign marks a rendezvous location for Lyft and Uber users at San Diego State University in San Diego, California, May 13, 2020. Mike Blake | Reuters Check out the companies making headlines in midday...

Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion

Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...

Starbucks, Uber, CVS to Report Earnings Amid Shrinking Economy

July 30, 2022 10:00 am ET Listen to article (2 minutes) CVS Health Starbucks and Uber Technologies are among the companies headlining another busy earnings week as investors look for signs of a recess...

Dow Jones Giant Amgen Leads 5 Stocks To Watch Near Buy Points

Your stocks to watch for the week ahead are Amgen (AMGN), Fortinet (FTNT), Ulta Beauty (ULTA), SQM (SQM) and Neurocrine Biosciences (NBIX). Those stocks are either in bases or near key support levels....

The Days of Big Pharma Are Over. Big Biotech Is on Its Way.

W hen GlaxoSmithKline spins off its enormous division selling drugstore staples like Advil and Tums next month, it will represent more than just the latest shuffling of assets among corporate giants. ...

Apple Needs to Show Some Spark as Shoppers Favor Services Over Stuff

Customers at the Apple Store in Grand Central Terminal in New York City earlier this year. Getty Images Text size As Apple prepares to upgrade its products, there are two distinct trends hitting the e...

Stocks Are Ready for a Bounce Higher After S&P 500 Closes Above Bear Market

Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20% off its peak in early January. Many investors would like to see it get there so Wall Street ...

Should you buy Amgen after robust earnings take stock higher?

Amgen Inc. (NASDAQ:AMGN) has been robust lately. The stock established a strong support at the oversold level of $233 in early May. The main catalyst for the gains in Amgen stock has been its quarterl...

‘Bizarre’ Potential $7.1 Billion Tax Bill Sinks Amgen Shares

(Bloomberg) — Shares of Amgen Inc. fell the most in a year after the company disclosed that it is facing a potential tax bill of at least $7.1 billion from the U.S. Internal Revenue Service. Mos...

Analyzing The Kroger Company’s Dividend Growth Potential

CINCINNATI – JULY 15: A sign identifies the Kroger Co. corporate headquarters July 15, 2008 in … [+] downtown Cincinnati, Ohio. Kroger is one of the nation’s largest grocery retailer...

Stocks for the Recession That May—or May Not—Be Coming

Text size Exelon stock offers a little bit of offense to go with its defense. Dreamstime The yield curve briefly inverted this past week—and that’s a recession signal that is either like Paul Revere’s...

Amgen Stock Remains In Limbo As Its Biggest Product Flounders

Amgen (AMGN) reported soaring fourth-quarter earnings Monday, but sales didn’t inch up enough to top Wall Street’s expectations — leaving Amgen stock in limbo. X During the fourth quarter,...

Why Alphabet, Nvidia, and Others Belong in the Dow Jones Industrials

The Dow Jones Industrial Average, launched in 1896, has trailed the S&P 500 index of late. That could change if Alphabet , which said on Tuesday that it would split its stock 20-1 (cutting shares ...

Amgen price outlook ahead of FQ4 earnings

Amgen (NASDAQ: AMGN) will announce fourth-quarter earnings results this Monday, February 07, after the market closes. Amgen shares have weakened slightly above 1% since the beginning of the 2022 year,...

Intel Joins the Dogs of the Dow. Why These Stocks Could Be a Good Strategy This Year.

Text size Sign at Intel headquarters in Santa Clara, Calif. Intel joins the so-called Dogs of the Dow for 2022. David Paul Morris/Bloomberg Intel will join the Dogs of the Dow for 2022, replacing Cisc...